Paradoxical Cerebral Perfusion in Parkinson’s Disease Patients with Orthostatic Hypotension: A Dual-Phase 18F-Florbetaben Positron Emission Tomography Study

Initial Versus Follow-up Sequential Myocardial 123I-MIBG Scintigraphy to Discriminate Parkinson Disease From Atypical Parkinsonian Syndromes

(2019) Dong-Woo Ryu et al.   CLINICAL NUCLEAR MEDICINE

Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET

(2019) Seung Hyun Son et al.   CLINICAL NUCLEAR MEDICINE

Automated anatomical labelling atlas 3

(2019) Edmund T. Rolls et al.   NEUROIMAGE

Orthostatic hypotension in Parkinson disease

(2019) Ylva Hivand Hiorth et al.   NEUROLOGY

Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases

(2019) David G. Coughlin et al.   MOVEMENT DISORDERS

Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer’s Disease

(2018) Lisa Florek et al.   JOURNAL OF ALZHEIMERS DISEASE

Evaluation of early-phase [ 18 F]-florbetaben PET acquisition in clinical routine cases

(2017) Sonja Daerr et al.   NeuroImage-Clinical

Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts

(2017) Usman Saeed et al.   Translational Neurodegeneration

Dual-phase amyloid PET: hitting two birds with one stone

(2016) Garibotto Valentina et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease

(2016) Corey T McMillan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Metabolic Imaging in Parkinson Disease

(2016) Sanne K. Meles et al.   JOURNAL OF NUCLEAR MEDICINE

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets

(2016) Alberto J Espay et al.   LANCET NEUROLOGY

Nonmotor features of Parkinson's disease subtypes

(2016) Connie Marras et al.   MOVEMENT DISORDERS

The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

(2015) William E. Klunk et al.   Alzheimers & Dementia

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study

(2015) Osama Sabri et al.   Alzheimers & Dementia

Parkinson’s disease dementia: a neural networks perspective

(2015) James Gratwicke et al.   BRAIN

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study

(2015) Anette Schrag et al.   LANCET NEUROLOGY

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Survival in synucleinopathies

(2015) David S. Goldstein et al.   NEUROLOGY

Cerebral autoregulation and white matter lesions in Parkinson's disease and multiple system atrophy

(2015) Elisabetta Indelicato et al.   PARKINSONISM & RELATED DISORDERS

New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression

(2015) Seyed-Mohammad Fereshtehnejad et al.   JAMA Neurology

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer’s disease and mild cognitive impairment

(2014) Niklas Mattsson et al.   BRAIN

The neurobiological basis of cognitive impairment in Parkinson's disease

(2014) Glenda M. Halliday et al.   MOVEMENT DISORDERS

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Blood Pressure and Progression of Brain Atrophy

(2013) Hadassa M. Jochemsen   JAMA Neurology

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

(2011) Roy Freeman et al.   CLINICAL AUTONOMIC RESEARCH

Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis

(2011) Samay Jain et al.   NEUROBIOLOGY OF DISEASE

The locus coeruleus and noradrenergic modulation of cognition

(2009) Susan J. Sara   NATURE REVIEWS NEUROSCIENCE